Retroviral protease inhibiting compounds
US6472529B2 · kind B2 · utility
2Cited by
22References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2001 |
| Grant date | Oct 29, 2002 |
| Priority date | — |
| Expiry date | Apr 18, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of the formula: is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.